Protein prenylation is required for aldosterone-stimulated Na+ transport.
Aldosterone stimulation of transcellular Na+ flux in polarized epithelial cells is dependent on at least one transmethylation reaction, but the substrate of this signaling step is unknown. Because it is clear that the majority of cellular protein methylation occurs in conjunction with protein prenylation, we examined the importance of prenylation to aldosterone-stimulated Na+ transport in the A6 cell line. Lovastatin, an inhibitor of the first committed step of the mevalonate pathway, inhibits the natriferic effect of aldosterone but does not inhibit insulin-stimulated Na+ flux. The addition of a farnesyl group does not appear to be involved in aldosterone's action. Neither alpha-hydroxyfarne-sylphosphonic acid, an inhibitor of farnesyl:protein transferase, nor N-acetyl-S-farnesyl-L-cysteine, an inhibitor of farnesylated protein methylation, inhibits the hormone-induced increase in Na+ transport. In contrast, N-acetyl-S-geranyl-geranyl-L-cysteine, an inhibitor of geranylgeranyl protein methylation, completely abolishes the aldosterone-induced increase in Na+ flux with no effect on insulin-mediated Na+ transport or cellular protein content. These data indicate that methylation of a geranylgeranylated protein is involved in aldosterone's natriferic action.
Blazer-Yost
B L
BL
Biology Department, Indiana University/Purdue University at Indianapolis, USA.
Hughes
C L
CL
Nolan
P L
PL
D000111:Acetylcysteine / Q000031:analogs & derivatives / Q000494:pharmacology; D000450:Aldosterone / Q000494:pharmacology*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002460:Cell Line; D003545:Cysteine / Q000031:analogs & derivatives / Q000494:pharmacology; D004122:Dimethylallyltranstransferase / Q000037:antagonists & inhibitors; D004224:Diterpenes / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004848:Epithelium; D005204:Farnesol / Q000031:analogs & derivatives / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D007668:Kidney; D007700:Kinetics; D008148:Lovastatin / Q000494:pharmacology*; D063065:Organophosphonates / Q000494:pharmacology; D017368:Protein Prenylation / Q000187:drug effects; D012964:Sodium / Q000378:metabolism*
C080570:(alpha-hydroxyfarnesyl)phosphonic acid; D004224:Diterpenes; D004791:Enzyme Inhibitors; D007328:Insulin; C095716:N-acetyl-S-geranylgeranyl-cysteine; D063065:Organophosphonates; D005204:Farnesol; D000450:Aldosterone; D008148:Lovastatin; D012964:Sodium; D004122:Dimethylallyltranstransferase; D003545:Cysteine; C068268:N-acetyl-S-farnesylcysteine; D000111:Acetylcysteine